OX40 ligand (OX40L), a member of the TNF family, was shown to be capab
le of signaling both the cells on which it is expressed and those expr
essing OX40, its cognate receptor. Here we show that OX40L is expresse
d on dendritic cells (DC), the mast efficient APC to prime naive T cel
ls. The expression and the functional activity of OX40L were examined
by means of mAbs used to stain or cross-link OX40L on 1) freshly isola
ted human blood DC (bDC) and 2) monocyte-derived DC at different stage
s of differentiation. These were derived from monocytes cultured eithe
r with IL-4 and granulocyte-macrophage CSF (IL-4-Mo-DC) or with IL-4 a
nd granulocyte-macrophage CSF plus TNF-alpha. Both types of Mo-DC expr
essed OX40L after stimulation through CD40; ligation of OX40L on activ
ated IL-4-Mo-DC enhanced by 4- to 35-fold their cytokine production (T
NF-alpha, IL-12 p40, IL-1 beta, and IL-6) and increased CD80, CD86, CD
54, and CD40 expression. Stimulation of activated IL-4-Mo-DC through O
X40L strikingly enhanced their maturation as evidenced by CD83 up-regu
lation, CD115 (CSF-1R) down-regulation, and typical morphologic change
s. OX40L was constitutively expressed on a subset of bDC, and its liga
tion slightly enhanced CD40L-stimulated IL-12 production. OX40L was do
wn-regulated after overnight culture and spontaneously reexpressed on
a subset of mature bDC (CD83(high), CD33(high), CD11c(high), CD5(+)).
Thus, the expression of OX40L on DC suggests a physiologic role of thi
s molecule during T cell priming by virtue of its ability to costimula
te both T cell and DC activation and differentiation.